Franklin Biotechnology Discovery Fund (FBTDX) is an MF managed by Franklin Templeton. Its largest position is Jazz Pharmaceuticals plc (JAZZ), representing 5.55% of fund assets.
Franklin Biotechnology Discovery Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- FBTDX
- Type:
- MF
- Manager:
- Franklin Templeton
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 24, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
Jazz Pharmaceuticals plc
|
5.55% | $57,469,480.46 | 283,073 |
|
-
AMGEN INC
|
4.75% | $49,158,497.50 | 141,974 |
|
-
GILEAD SCIENCES, INC.
|
4.66% | $48,279,829.16 | 368,999 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
4.16% | $43,144,094.14 | 61,019 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
4.02% | $41,642,197.68 | 97,436 |
|
-
ARGENX SE
|
3.69% | $38,274,574.64 | 48,962 |
|
-
INSTITUTIONAL FIDU
|
3.05% | $31,626,763.00 | 31,626,763 |
|
-
INSTITUTIONAL FIDU
|
2.96% | $30,710,464.71 | 30,710,465 |
|
-
Ascendis Pharma A/S
|
2.87% | $29,760,219.96 | 129,742 |
|
-
INSMED Inc
|
2.82% | $29,217,427.62 | 214,314 |
|
-
Revolution Medicines, Inc.
|
2.82% | $29,174,211.60 | 202,430 |
|
-
Praxis Precision Medicines, Inc.
|
2.51% | $25,961,051.58 | 81,426 |
|
-
Dianthus Therapeutics, Inc. /DE/
|
2.30% | $23,776,152.20 | 270,799 |
|
-
Guardant Health, Inc.
|
2.09% | $21,681,613.80 | 248,985 |
|
-
Mirum Pharmaceuticals, Inc.
|
2.02% | $20,940,138.90 | 215,190 |
|
-
PTC THERAPEUTICS, INC.
|
2.01% | $20,796,559.12 | 319,652 |
|
-
ASTRAZENECA PLC
|
1.85% | $19,211,233.47 | 102,531 |
|
-
NEUROCRINE BIOSCIENCES INC
|
1.72% | $17,811,395.91 | 135,273 |
|
-
BridgeBio Pharma, Inc.
|
1.66% | $17,145,972.09 | 241,119 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.62% | $16,755,169.62 | 54,138 |
|
-
Abivax S.A.
|
1.60% | $16,559,970.40 | 141,080 |
|
-
Spyre Therapeutics, Inc.
|
1.58% | $16,379,000.00 | 220,000 |
|
-
IONIS PHARMACEUTICALS INC
|
1.48% | $15,355,704.00 | 205,400 |
|
-
Oruka Therapeutics, Inc.
|
1.47% | $15,213,905.13 | 222,393 |
|
-
Mineralys Therapeutics, Inc.
|
1.46% | $15,125,074.25 | 567,545 |
|
-
EyePoint, Inc.
|
1.43% | $14,830,134.00 | 1,123,495 |
|
-
ELI LILLY & Co
|
1.27% | $13,150,756.60 | 14,071 |
|
-
CG Oncology, Inc.
|
1.21% | $12,563,137.60 | 188,240 |
|
-
Indivior Pharmaceuticals, Inc.
|
1.18% | $12,229,202.88 | 332,496 |
|
-
Benitec Biopharma Inc.
|
1.16% | $11,991,581.60 | 995,152 |
|
-
Arcutis Biotherapeutics, Inc.
|
1.13% | $11,741,216.22 | 505,651 |
|
-
Syndax Pharmaceuticals Inc
|
1.02% | $10,559,482.49 | 492,743 |
|
-
Amylyx Pharmaceuticals, Inc.
|
1.00% | $10,388,144.00 | 649,259 |
|
-
CYTOKINETICS INC
|
0.99% | $10,303,200.11 | 161,063 |
|
-
BeOne Medicines Ltd.
|
0.95% | $9,868,218.67 | 33,421 |
|
-
Tango Therapeutics, Inc.
|
0.93% | $9,677,868.70 | 447,635 |
|
-
Dyne Therapeutics, Inc.
|
0.88% | $9,112,521.60 | 519,232 |
|
-
Solid Biosciences Inc.
|
0.88% | $9,103,880.28 | 1,253,978 |
|
-
Bicara Therapeutics Inc.
|
0.81% | $8,360,135.16 | 387,402 |
|
-
Vaxcyte, Inc.
|
0.80% | $8,338,379.76 | 145,674 |
|
-
Alkermes plc.
|
0.76% | $7,852,306.27 | 232,937 |
|
-
Spyre Therapeutics, Inc.
|
0.74% | $7,711,828.80 | 103,584 |
|
-
BioNTech SE
|
0.73% | $7,593,230.00 | 73,400 |
|
-
NUVALENT INC-A
|
0.73% | $7,574,649.80 | 75,535 |
|
-
Xenon Pharmaceuticals Inc.
|
0.67% | $6,935,902.68 | 123,767 |
|
-
ACHIEVE LIFE SCIENCES, INC.
|
0.67% | $6,917,243.98 | 1,575,682 |
|
-
APOGEE THERAPEUTICS INC
|
0.66% | $6,858,069.93 | 82,737 |
|
-
Oric Pharmaceuticals, Inc.
|
0.63% | $6,510,969.40 | 659,005 |
|
-
Oruka Therapeutics, Inc.
|
0.62% | $6,432,797.53 | 94,033 |
|
-
Alto Neuroscience, Inc.
|
0.59% | $6,163,660.30 | 240,205 |
Advertisement (320x50)